EP3934607A1 - Préparation cosmétique contenant un dérivé d'amidon - Google Patents

Préparation cosmétique contenant un dérivé d'amidon

Info

Publication number
EP3934607A1
EP3934607A1 EP20706178.9A EP20706178A EP3934607A1 EP 3934607 A1 EP3934607 A1 EP 3934607A1 EP 20706178 A EP20706178 A EP 20706178A EP 3934607 A1 EP3934607 A1 EP 3934607A1
Authority
EP
European Patent Office
Prior art keywords
weight
emulsion
proportion
total weight
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20706178.9A
Other languages
German (de)
English (en)
Inventor
Lisa Peschke
Thomas Raschke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of EP3934607A1 publication Critical patent/EP3934607A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes

Definitions

  • Emulsions are generally understood to mean heterogeneous systems which consist of two liquids which are immiscible or only partially miscible with one another, which are usually referred to as phases and in which one of the two liquids is in the form of very fine droplets in the other
  • Liquid is dispersed. Externally and with the naked eye, emulsions appear homogeneous.
  • the two liquids are water and oil and if oil droplets are finely distributed in water, then it is an oil-in-water emulsion (O / W emulsion, e.g. milk).
  • O / W emulsion oil-in-water emulsion
  • the basic character of an O / W emulsion is shaped by the water.
  • W / O emulsion water-in-oil emulsion, e.g. butter
  • the principle is reversed, the basic character being determined here by the oil.
  • Acrylate-based polymers are usually incorporated into these formulations to stabilize and thicken O / W emulsions.
  • the acrylate-based polymers include polymers which are obtained from homo- or copolymerization with acrylic and / or methacrylic acid. Examples of this include Carbomer or Acrylate Copolymer.
  • polymers are based on
  • sodium carboxymethyl starch is used in combination with acrylate-based polymers.
  • the object of the present invention was to provide stable cosmetic emulsions.
  • stable means that no phase or water separations occur within 30 days when stored below 40 ° C.
  • the invention relates to a cosmetic emulsion containing
  • At least one emulsifier selected from the group
  • composition or specific mixture are given, then these details always relate to the total weight of the cosmetic emulsion.
  • ratios of components / substances / groups of substances relate to weight ratios of the named ones
  • normal conditions means 20 ° C, 1013 hPa and a relative humidity of 50%.
  • skin it preferably refers to human skin.
  • Sodium carboxymethyl starch with GAS no. 9063-38-1 has the INCI name Sodium carboxy methyl starch. It is preferred according to the invention if the
  • Sodium carboxymethyl starch based on potato starch It is particularly preferred not to use any other starches besides potato starch for the production of sodium carboxymethyl starch.
  • Potato starch is known under the trade name COVAGEL from LCW. Further sodium carboxymethyl starches according to the invention can be obtained under the trade names GLYCOLYS from Roquette and VIVASTAR P3500 and VIVASTAR CS INSTANT Powder from JRS Pharma.
  • Sodium carboxymethyl starch from the range from 0.5 to 5% by weight, further preferably from the range from 1 to 4% by weight and particularly preferably from the range from 2 to 3% by weight, each based on the total weight of the emulsion choose. Furthermore, it is advantageous in the context of the invention if the total proportion of polyglyceryl stearates and fatty acids having 14 to 22 carbons and / or their salts is from 0.1 to 5% by weight, preferably from 0.5 to 4% by weight. % and particularly preferably from 1 to 3% by weight based on the total weight of the emulsion.
  • the total proportion of polyglyceryl stearates and fatty acids having 14 to 22 carbons and / or their salts is from 0.1 to 5% by weight, preferably from 0.5 to 4% by weight. % and particularly preferably from 1 to 3% by weight based on the total weight of the emulsion.
  • Total proportion of emulsifiers b) advantageously from 0.1 to 5% by weight, preferably from 0.5 to 4% by weight and particularly preferably from 1 to 3% by weight, based on the total weight of the emulsion.
  • the emulsion has one or more fatty acids having 14 to 22 carbon atoms and / or their salts in a proportion of 0.1 to 5% by weight, preferably 0.5 to 4% by weight and particularly preferably from 1 to 3% by weight based on the total weight of the emulsion.
  • Embodiment it is preferred if at least stearic acid and / or palmitic acid or their salts are included.
  • the emulsion contains polyglyceryl stearate in a proportion of 0.1 to 5% by weight, preferably 0.5 to 4% by weight and particularly preferably 0.8 to 3% by weight % By weight based on the total weight of the emulsion.
  • the emulsion does not contain any acrylate-based polymers.
  • Acrylate-based polymers are polymers that are obtained from homo- or copolymerization with acrylic and / or methacrylic acid. Examples of this include Carbomer or Acrylate Copolymer.
  • the cosmetic emulsion contains glyceryl stearate. If the emulsion contains glyceryl stearate, it is preferred if the proportion of glyceryl stearate is from 0.1 to 3% by weight, preferably from 0.2 to 2% by weight and particularly preferably from 0.5 to 1.5% by weight .-% based on the
  • the cosmetic emulsion of the invention has at least one fatty alcohol with a chain length of 14 to 22 carbon atoms, in particular
  • the cosmetic emulsion has at least one or more fatty alcohols with a chain length of 14 to 22 carbon atoms, in particular Contains cetyl alcohol, stearyl alcohol and / or behenyl alcohol, it is preferred if the proportion of these fatty alcohols is from 0.1 to 4.5% by weight, preferably 1 to 4% by weight and particularly preferably 1.5 to 3% by weight, 5% by weight based on the total weight of the emulsion.
  • An advantageous embodiment contains at least behenyl alcohol as fatty alcohol and is characterized in that the proportion of behenyl alcohol is 0.5 to 5% by weight, preferably 1.2 to 4% by weight and particularly preferably 1.8 to 3.5% by weight .-% based on the total weight of the emulsion. Within this embodiment it is also preferred if no further fatty alcohols are present besides behenyl alcohol. Surprisingly, this embodiment is characterized in that, in addition to advantageous stability, particularly fine-pored or fine-bubble foam structures can also be formed in the emulsion without the emulsion having to be foamed with air or propellant gas. Foam structures are understood as inclusions of air.
  • polysaccharides with the exception of polysaccharides which have been modified with acrylic acid or methacrylic acid.
  • preferred polymers are, inter alia, polymers based on celluloses, particularly preferably selected from the group carboxymethyl cellulose, hydroxyethyl cellulose,
  • Hydroxypropyl cellulose ethyl cellulose, methyl cellulose, ethyl hydroxyethyl cellulose and methyl ethyl cellulose.
  • polymers are selected from the group of polymers based on starches, particularly preferably selected from the group Hydroxypropyl Starch Phosphate, Sodium Hydroxypropyl Starch Phosphate, Hydroxypropyl Starch Phosphate and Distarch Phosphate.
  • Another preferred polymer is Xantham Gum.
  • polystyrene resin Sclerotium Gum, Locust Bean Gum and / or Gellan Gum.
  • Polysaccharides with the exception of polysaccharides, which with acrylic acid or
  • Methacrylic acid were modified, from 0.05 to 5 wt .-%, particularly preferably from 0.1 to 1 wt .-%, preferably based on the total weight of the emulsion is. It is particularly advantageous if it contains xanthan gum, sclerotium gum, locust bean gum and / or gellan gum and the proportion of these substances is preferably from 0.05 to 0.5% by weight, the information relating to the total weight of the Emulsion relates.
  • the emulsion of the present invention is advantageously characterized in that it is an oil-in-water emulsion.
  • the proportion of the oil phase is from 3 to 20% by weight, preferably from 6 to 15% by weight, emulsifiers and surfactants by definition not being part of the oil phase and the information relating to the total weight of the emulsion.
  • Emulsifiers are understood to mean all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the designation “emulsifying agent”. Everyone is under surfactants
  • oil phase or the emulsion, is Caprylic / Capric
  • the emulsion contains caprylic / capric triglyceride
  • the proportion of caprylic / capric triglyceride is advantageously from 0.5 to 15% by weight, preferably from 1 to 14% by weight and particularly preferably from 7 to 13% by weight, based on the total weight of the emulsion.
  • the oil phase or the emulsion contains hydrogenated coconut oil (INCI: hydrogenated coco glycerides). If hardened coconut oil is contained in the emulsion, the proportion of hardened coconut oil is advantageously from 0.1 to 3% by weight, preferably from 0.2 to 1.5% by weight, based on the total weight of the emulsion.
  • esters of monohydric alcohols and monocarboxylic acids to be chosen advantageously are 2-ethylhexyl isostearate, isotridecyl isononanoate, 2-ethylhexyl cocoate, C 12-15 alkyl benzoate, isopropyl myristate and isopropyl palmitate It is also advantageous in the context of the present invention if the emulsion of the present invention contains one or more dialkyl ethers having 12 to 24 carbon atoms, dicaprylyl ether being preferably included. If the emulsion contains dicaprylyl ether, the proportion of dicaprylyl ether is preferably from 0.5 to 3% by weight, based on the total weight of the emulsion.
  • the emulsions according to the invention can advantageously be vegetable oils, such as preferably sunflower oil (Helianthus Annuus Seed Oil), rapeseed oil (Canola Oil), soybean oil (Glycine Soja Oil), olive oil (Olea Europaea Fruit Oil), almond oil (Prunus amygdalus dulcis Oil), avocado oil ( Persea Gratissima Oil), Walnut Oil (Junglans Regia Seed Oil), Peach Kernel Oil (Prunus Persica Kernel Oil), Apricot Kernel Oil (Prunus Armeniaca Kernel Oil), Sesame Oil (Sesamum Indicum Seed Oil), Camelia Oil (Camelia Oleifera / Camelia Sasanqua),
  • vegetable oils such as preferably sunflower oil (Helianthus Annuus Seed Oil), rapeseed oil (Canola Oil), soybean oil (Glycine Soja Oil), olive oil (Olea Europaea Fruit Oil), almond oil (Prunus amygdalus dulcis Oil
  • primrose oil (Oenothera biennis), macadamia nut oil (Macadamia Intergrifolia Seed Oil), diestel oil (Silybum Marianum Seed Oil), wheat germ oil (Triticum Vulgare Germ Oil),
  • Palm kernel oil (Elaeis guineensis Kernel Oil), palm oil (Elaeis guineensis Oil), grape seed oil (Vitis Vinifera Seed Oil), argan oil (Argania spinosa Seed Oil), peanut oil (Arachis hypogaea Oil), pumpkin seed oil (Cucurbita Pepo Seed Oil), castor oil (Ricinus Communis Seed Oil) Seed Oil), Rice Germ Oil (Oryza Sativa Bran Oil), Vegetable Oil (Olus Oil) and / or coconut oil.
  • the emulsion of the present invention contains one or more branched and / or unbranched hydrocarbons, provided these are not gaseous under normal conditions.
  • Hydrocarbons to be used advantageously are
  • Caprylic / Capric Triglyceride Octyldodecanol, Dicaprylylether, Dimeticone, C12-15
  • Alkyl benzoate and dicaprylyl carbonate Octyl cocoate, cetearyl isononanoate,
  • Isopropyl palmitate, cocoglycerides, squalane, and / or a vegetable oil are included and their respective or individual portion, if the respective oil is included, advantageously from 0.5 to 10 wt .-%, particularly preferably from 1 to 5 wt. % based on the
  • the cosmetic emulsion contains ethanol, the proportion of ethanol preferably being from 0.5 to 5% by weight, particularly preferably from 1 to 3% by weight, based on the total weight of the emulsion.
  • advantageous emulsions are characterized in that they contain butylenes glycol, the proportion of butylenes glycol preferably being from 0.5 to 7% by weight and particularly preferably from 1 to 6% by weight based on the total weight of the emulsion.
  • the emulsion contains propylene glycol, 2-methylpropane-1,3-diol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, glyceryl caprylate and / or 1,2-decanediol contains.
  • the emulsion is phenoxyethanol, methyl paraben, ethyl paraben, dehydracetic acid and / or
  • the emulsion contains phenoxyethanol, it is preferred if the proportion of
  • Phenoxyethanol is from 0.2 to 1.0 wt .-%, based on the total weight of the emulsion.
  • the emulsion contains methyl paraben and / or ethyl paraben, it is preferred if the total proportion of methyl paraben and / or ethyl paraben is from 0.01 to 0.5% by weight, based on the total weight of the emulsion.
  • the emulsion has one or more active ingredients selected from the group of the compounds glycyrrhetinic acid, urea, arctic acid, folic acid, coenzyme Q10 (ubiquinone), alpha-glucosyl rutin, carnitine, carnosine, caffeine, natural and / or synthetic
  • Isoflavonoids glycerylglucose, creatine, creatinine, taurine, tocopherol, tocopherol acetate 7 vitamin C, vitamin C phosphate, vitamin C palmitate, niacinamide, vitamin A palmitate, panthenol, licochalcone A, rucinol, N - [(2,4-dihydroxyphenyl) thiazole- 2-yl] isobutyramide, honociol and magnolol (also as a component of magnolia extracts), hyaluronic acid and / or silymarin (milk thistle extract).
  • the emulsion of the present invention additionally contains at least one UV-A, UV-B and / or broadband filter substance.
  • Particularly advantageous UV filter substances which are liquid at room temperature in the context of the present invention are homomenthyl salicylate (INCI: Homosalate), 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate (INCI: Octocrylene), 2-ethylhexyl-2-hydroxybenzoate ( 2-ethylhexyl salicylate, Octyl salicylate, INCI: Octyl Salicylate) and esters of cinnamic acid, preferably 4-methoxycinnamate (2-ethylhexyl) ester (2-ethylhexyl-4-methoxycinnamate, INCI: Octyl methoxycinnamate).
  • the inventive capsules are dibenzoylmethane derivatives, in particular 4- (tert-butyl) -4'-methoxydibenzoylmethane (CAS-Nr. 70356-09-1), marketed by Givaudan under the trade name Parsol ® 1789 and from Merck under the trade name Eusolex ® 9020 is sold.
  • UV filter substances are sulfonated, water-soluble UV filters, such as. B .:
  • Phenylene-1,4-bis- (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid and its salts especially the corresponding sodium, potassium or triethanolammonium salts, especially phenylene-1,4 -bis- (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid-bis-sodium salt with the INCI name Bisimidazylate (CAS-No .: 180898-37-7), which is available, for example, under the trade name Neo Heliopan AP is available from Haarmann &Reimer;
  • Advantageous broadband filters are, for example, triazine derivatives such. B.
  • the emulsion does not contain any silicone oils or silicone-containing substances.
  • the emulsion contains at least one silicone oil. It is particularly advantageous to use silicone oil in combination with dyes and / or color pigments. It is therefore advantageous contain at least one silicone oil, particularly advantageously dimethicone, and at least one dye and / or color pigment. However, it is also possible according to the invention to use one or more dyes and / or color pigments without dimethicones.
  • the dyes and color pigments can be selected from the corresponding positive list of the Cosmetics Directive or the EC list of cosmetic dyes. In most cases, they are identical to the food-approved colorings.
  • Advantageous color pigments are, for example, titanium dioxide, mica, iron oxides (e.g.
  • Advantageous dyes are, for example, carmine, Prussian blue, chromium oxide green, ultramarine blue and / or manganese violet. It is particularly advantageous to select the dyes and / or color pigments from the list below.
  • the color index numbers (CIN) come from the Rowe Color Index, 3rd edition, Society of Dyers and Colourists,
  • treated in the table above means in the context of the present disclosure that a pigment has been treated with the respective substance, so that the substance used in each case is deposited on the surface of the pigment.
  • the emulsions of the present invention thus advantageously contain at least one inorganic pigment. It has been found to be particularly advantageous if the emulsion is characterized in that inorganic pigments in a proportion of 4 to 15% by weight, preferably 5 to 10% by weight, based on the
  • the emulsion according to the invention contains glycerol in a proportion of 0.5 to 10% by weight, preferably 2.5 to 8% by weight, based on the total weight of the emulsion.
  • emulsions advantageous according to the invention are characterized in that they contain water in a proportion of 55 to 95% by weight and preferably 60 to 80% by weight, based on the total weight of the emulsion.
  • phase D is added to the formulation and sufficiently incorporated.
  • the OW emulsions 8 and 11 represent emulsions according to the invention, while all other emulsions are comparative examples not according to the invention.
  • Examples 1 to 3 contain Glyceryl Stearate Citrate, which is an effective and effective emulsifier for O / W emulsions. It also became an emulsion without
  • Examples 4, 5 and 6 each contain an emulsifier selected from the group
  • Emulsion 7 contained only the emulsifier polyglyceryl-10 stearate and none
  • Emulsion 8 is an example according to the invention containing polyglyceryl-10 stearate and sodium carboxymethyl starch. The combination is completely stable after 30 days below 40 ° C. No phase separation or water separation is perceptible.
  • Emulsion 9 contained tapioca starch and polyglyceryl-10 stearate, but none
  • the emulsion 10 contained only a fatty acid mixture according to the invention as an emulsifier, but no sodium carboxymethyl starch. After 30 days of storage below 40 ° C., this emulsion showed aqueous deposits and can therefore be classified as unstable.
  • Emulsion 11 is an example according to the invention containing a fatty acid mixture according to the invention as an emulsifier and sodium carboxymethyl starch. The combination is completely stable after 30 days below 40 ° C. There is no phase separation or
  • Emulsion 12 contained tapioca starch and a fatty acid mixture according to the invention as an emulsifier, but no sodium carboxymethyl starch. After 30 days of storage below 40 ° C., this emulsion showed aqueous deposits and can therefore be classified as unstable.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

Émulsion cosmétique contenant du carboxyméthylamidon de sodium et au moins un émulsifiant choisi dans le groupe du polyglycéryl-10 stéarate, et d'acides gras contenant 14 à 22 atomes de carbones ou leurs sels.
EP20706178.9A 2019-03-08 2020-02-17 Préparation cosmétique contenant un dérivé d'amidon Pending EP3934607A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102019203197.8A DE102019203197A1 (de) 2019-03-08 2019-03-08 Kosmetische Zubereitung enthaltend ein Stärkederivat
PCT/EP2020/054023 WO2020182417A1 (fr) 2019-03-08 2020-02-17 Préparation cosmétique contenant un dérivé d'amidon

Publications (1)

Publication Number Publication Date
EP3934607A1 true EP3934607A1 (fr) 2022-01-12

Family

ID=69631558

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20706178.9A Pending EP3934607A1 (fr) 2019-03-08 2020-02-17 Préparation cosmétique contenant un dérivé d'amidon

Country Status (3)

Country Link
EP (1) EP3934607A1 (fr)
DE (1) DE102019203197A1 (fr)
WO (1) WO2020182417A1 (fr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938756A1 (de) 1999-08-16 2001-02-22 Beiersdorf Ag Dünnflüssige kosmetische oder dermatologische Zubereitungen vom Typ Öl-in-Wasser
DE29924371U1 (de) 1999-09-15 2002-11-28 Beiersdorf Ag O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin
DE10113048A1 (de) * 2001-03-15 2002-09-19 Beiersdorf Ag Selbstschäumende oder schaumförmige Zubereitungen mit partikulären hydrophoben und/oder hydrophobisierten und/oder ölabsorbierenden Festkörpersubstanzen
DE10148825B4 (de) 2001-10-04 2004-10-07 Beiersdorf Ag O/W-Emulsionen mit unpolaren Wirkstoffen, deren kosmetische und/oder dermatologische Zubereitungen und deren Verwendung
FR2869226B1 (fr) 2004-04-22 2009-06-12 Oreal Composition de lavage et de conditionnement des matieres keratiniques comprenant un carboxyalkylamidon, utilisation et procede
DE102005056498A1 (de) 2005-11-28 2007-05-31 Beiersdorf Ag Kosmetische Hydrodispersionen
DE102005056497A1 (de) 2005-11-28 2007-05-31 Beiersdorf Ag Transparente oder transluzente Gele
KR101291839B1 (ko) * 2009-02-06 2013-07-31 더 프록터 앤드 갬블 캄파니 발수성 실리콘 탄성중합체 파우더를 포함하는 파운데이션 조성물
FR3002444B1 (fr) 2013-02-25 2015-03-13 Oreal Composition cosmetique de type gel
DE102014207602A1 (de) * 2014-04-23 2015-10-29 Beiersdorf Ag Emulsionsgrundlage für Sonnenschutzmittel

Also Published As

Publication number Publication date
DE102019203197A1 (de) 2020-09-10
WO2020182417A1 (fr) 2020-09-17

Similar Documents

Publication Publication Date Title
EP2937073B1 (fr) Base d'émulsion pour les produits de protection solairel
DE10333710A1 (de) Kosmetische, dermatologische oder pharmazeutische Zubereitungen auf Basis von Gase enthaltenden Lipid/Wachs-Gemischen
WO2014184228A1 (fr) Composition cosmétique comprenant une huile organique naturelle et des particules de polyméthacrylate de méthyle
WO2004030644A1 (fr) Emulsion contenant des saccharides substitues
DE102018214479A1 (de) Acrylatfreie kosmetische Emulsion
EP3843691A1 (fr) Émulsion cosmétique sans acrylate
WO2016207095A1 (fr) Produits de protection solaire pulvérisables présentant un mélange de cires défini
EP2717970A2 (fr) Compositions cosmétiques ou dermatologiques exemptes de polyéthylène glycol
EP3934607A1 (fr) Préparation cosmétique contenant un dérivé d'amidon
DE202005002183U1 (de) Hautverwöhnende Cremelotion
EP3930665A1 (fr) Émulsion h/e cosmétique exempte d'acrylate et de silicium
WO2021213760A1 (fr) Écran solaire écologique
EP3592328B1 (fr) Utilisation de sels de calcium dans des préparations cosmétiques
EP4103148A1 (fr) Préparation cosmétique exempte de polyacrylate
WO2004014325A1 (fr) Preparations cosmetiques a deux phases
WO2021063609A1 (fr) Écran solaire contenant de l'oxychlorure de bismuth pour protection contre la lumière bleue
DE10325767A1 (de) Verfahren zur Herstellung feindisperser, aber nicht transparenter Zubereitungen
DE102006055016A1 (de) Kosmetische Zubereitungen mit Guerbetalkoholen
WO2008058718A1 (fr) Emulsion au chlorure de diméthyldioctadécyclammonium
EP4021378A1 (fr) Émulsion h/e cosmétique exempte d'acrylate et de silicone
EP4281030A1 (fr) Émulsion e/h thermiquement stable et exempte d'huile minérale
WO2021037713A1 (fr) Substitut d'huile pour préparations cosmétiques
WO2020259989A1 (fr) Particules d'alginate de calcium
CN114269318A (zh) 用于化妆品制剂的特别是天然的油替代品
WO2020048837A1 (fr) Hydrodispersion matifiante

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211008

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BEIERSDORF AG

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS